EZR and breast carcinoma: In estrogen receptor (ER)-positive, noninvasive and nontumorigenic cell lines and breast cancer tissues, the expression of ezrin was more at the apical surface, while in invasive cell lines the expression was more in the localized membrane ruffles and filopodia proving that it plays a role in metastasis [196].